Erleada 240 mg film-coated tablets, Erleada 60 mg film-coated tablets, Docetaxel AqVida 20 mg/ml Konzentrat zur Herstellung einer Infusionslösung
REINFORCE
Phase 3 small_molecule active
Quick answer
Erleada 240 mg film-coated tablets, Erleada 60 mg film-coated tablets, Docetaxel AqVida 20 mg/ml Konzentrat zur Herstellung einer Infusionslösung for Metastatic hormone-sensitive prostate cancer is a Phase 3 program (small_molecule) at Disc Medicine with 1 ClinicalTrials.gov record(s).
Program details
- Company
- Disc Medicine
- Indication
- Metastatic hormone-sensitive prostate cancer
- Phase
- Phase 3
- Modality
- small_molecule
- Status
- active